Retrospective analysis of historical, clinical, ultrasonographic, serum biochemical and haematological data in prognostic evaluation of equine liver disease

2010 ◽  
Vol 35 (6) ◽  
pp. 542-547 ◽  
Author(s):  
A. E. DURHAM ◽  
J. R. NEWTON ◽  
K. C. SMITH ◽  
M. H. HILLYER ◽  
L. L. HILLYER ◽  
...  
Nutrients ◽  
2019 ◽  
Vol 11 (10) ◽  
pp. 2495
Author(s):  
Mikołaj Danko ◽  
Aleksandra Żyła-Pawlak ◽  
Janusz Książyk ◽  
Katarzyna Olszewska-Durkacz ◽  
Marta Sibilska ◽  
...  

Background: Deterioration of liver function, or intestinal failure-associated liver disease, is often observed in long-term parenterally fed children. Fish oil-based intravenous lipids have been reported to play a role in the prevention and treatment of intestinal failure associated liver disease. Methods: This retrospective analysis included 40 pediatric patients, (20 male and 20 female), median age 38 months (range 1.5–200 months) on long-term (≥1 month) parenteral nutrition who received the parenteral mixtures containing a combination of a third-generation lipid emulsion and pure fish oil because of laboratory liver function abnormalities. The total dose of fish oil from both emulsions for each patient exceeded 0.5 g/kg/day. Data from visits in an outpatient clinic were retrospectively analyzed using the Wilcoxon test, Mann-Whitney test, and Spearman correlation test. Results: The median time of therapy was 149 days (range 28–418 days). There was a decrease of median total and direct (conjugated) bilirubin concentration from 22.23 µmol/L (range 3.42–243 µmol/L) to 10.26 µmol/L (range 3.42–180.58 µmol/L; p < 0.005) and 8.55 (range 1.71–212.04 µmol/L) to 6.84 µmol/L (range 1.71–150.48 µmol/L; p < 0.007) respectively. A significant decrease in median alanine aminotransferase, aspartate aminotransferase and gamma-glutamyl transferase was also observed. In 11 patients bilirubin concentrations increased or remained unchanged. When compared to the patients who responded to the combination therapy, the patients who did not respond received parenteral nutrition for a longer time prior to the start of the therapy (51 vs. 30 months; p < 0.05). Conclusions: The mixture of an intravenous lipid emulsion containing soybean oil, medium-chain triglycerides, olive oil, and fish oil with the addition of pure fish oil emulsion may be helpful in the treatment of liver complications in children on long-term parenteral nutrition.


2016 ◽  
Vol 111 ◽  
pp. S367-S368
Author(s):  
Joydeep Chakraborty ◽  
Yaseen B. Perbtani ◽  
Jonathan J. Shuster ◽  
Jingnan Zhang ◽  
Tony S. Brar ◽  
...  

2017 ◽  
Vol 31 (3) ◽  
pp. 262-267 ◽  
Author(s):  
Sanjay Mohan ◽  
Mary Ann Howland ◽  
Daniel Lugassy ◽  
Jessica Jacobson ◽  
Mark K. Su

Background: PCC (Kcentra®) is an Food and Drug Administration (FDA)–approved 4-factor PCC used for the treatment of warfarin-related coagulopathy (WRC), but it has also been used off-label to treat non-WRC. Three-factor PCC in the form of coagulation factor IX human (Bebulin®) has also been used for WRC and off-label to treat non-WRC. It is unclear whether the use of 3- or 4-factor PCCs is effective for the treatment of non-WRC,. Objective: Our aim is to characterize the use of 3- and 4-factor PCCs for patients identified with a non-WRC. Methods: A retrospective analysis of patients who received PCCs for both WRC and non-WRC between January 2012 and July 2015 was conducted. Results: A total of 187 patients with elevated international normalized ratio (INR) who received PCCs were analyzed; 53.9% of patients in the WRC group and 27.7% in the non-WRC group corrected to an INR of 1.3 or less after 3- or 4-factor PCC administration. In those patients with non-WRC and who had underlying liver disease, 3- and 4-factor PCCs reduced mean INR by 0.98 and 1.43, respectively. Conclusion: Three and 4-factor PCCs can reduce INR in patients with WRC and in those with non-WRC secondary to liver disease.


2021 ◽  
Vol 24 ◽  
pp. 100382
Author(s):  
José Alfredo Salinas-Casanova ◽  
Daniel Almaguer-Morales ◽  
Salvador Bruno Valdovinos-Chávez ◽  
Luis Alonso Morales-Garza ◽  
María Teresa Sánchez-Ávila ◽  
...  

2020 ◽  
Vol 115 (1) ◽  
pp. S1704-S1705
Author(s):  
Aws Alameri ◽  
Tamneet Singh ◽  
Ahmed Oglah ◽  
Mahnoor Mir ◽  
Joel Michalek ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document